home / stock / ocx / ocx news


OCX News and Press, Oncocyte Corporation From 07/24/23

Stock Information

Company Name: Oncocyte Corporation
Stock Symbol: OCX
Market: NYSE
Website: oncocyte.com

Menu

OCX OCX Quote OCX Short OCX News OCX Articles OCX Message Board
Get OCX Alerts

News, Short Squeeze, Breakout and More Instantly...

OCX - Oncocyte to implement a 1-for-20 reverse stock split; shares fall 9%

2023-07-24 14:37:06 ET Oncocyte will implement a 1-for-20 reverse stock split reverse at 5p Pacific Time on Monday. Shares, which are down 9% Monday , will begin trading on a post-split basis on July 25. The reverse split will cut the number of outstanding shares to 8...

OCX - Oncocyte Announces 1-For-20 Reverse Stock Split

IRVINE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX) (the “Company”), a precision diagnostics company, announced today that the Company will implement a 1-for-20 reverse stock split of the outstanding shares of its common stock. The reverse stock...

OCX - Oncocyte Begins Manufacturing Transplant Blood Test

Over 1 million annual testing opportunities in US Q4 targeted for early access launch IRVINE, Calif., June 27, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that it has begun the manufacturing process for the dist...

OCX - Oncocyte Corporation to Present at the LD Micro Invitational XIII

Irvine, California--(Newsfile Corp. - June 1, 2023) - Oncocyte Corporation (NASDAQ: OCX) announced today that it will be presenting at the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel, California on June 6th-8th, 2023. The event is expected to feature 150+ companies, prese...

OCX - OncoCyte Corporation (OCX) Q1 2023 Earnings Call Transcript

2023-05-11 12:50:06 ET OncoCyte Corporation (OCX) Q1 2023 Earnings Conference Call May 11, 2023, 9:00 AM ET Company Participants Stephanie Prince - PCG Advisory, IR Josh Riggs - President and CEO Anish John - Chief Financial Officer Conference Call Particip...

OCX - OncoCyte GAAP EPS of $0.04 beats by $0.13, revenue of $0.3M misses by $0.04M

2023-05-11 08:06:35 ET OncoCyte press release ( NASDAQ: OCX ): Q1 GAAP EPS of $0.04 beats by $0.13 . Revenue of $0.3M (-21.1% Y/Y) misses by $0.04M . For further details see: OncoCyte GAAP EPS of $0.04 beats by $0.13, revenue of $0.3M misses by $0.04M

OCX - Oncocyte Reports First Quarter 2023 Financial Results

IRVINE, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the first quarter 2023, ended March 31, 2023. First Quarter 2023 and Recent Highlights: Completed an equity capit...

OCX - Notable earnings before Thursday's open

2023-05-10 11:12:09 ET Major earning expected before the bell on Thursday include: Fiverr International ( FVRR ) Himax Technologies ( HIMX ) JD.com ( JD ) Marathon Digital Holdings ( MARA ) Tapestry ( TPR ) For further details see: Notable...

OCX - Oncocyte To Announce First Quarter 2023 Financial Results

IRVINE, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that it will release its first quarter 2023 financial results on Thursday, May 11, 2023, before U.S. market open. The company will host a conference cal...

OCX - Oncocyte Presents New Data at AACR

IRVINE, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that five posters of original research are being presented at the Annual Meeting of the American Association for Cancer Research. Four abstracts explore ...

Previous 10 Next 10